Q1 EPS Estimate for Bicara Therapeutics Lowered by Analyst
Bicara Therapeutics Inc. (NASDAQ:BCAX – Free Report) – Equities research analysts at Wedbush cut their Q1 2025 EPS estimates for Bicara Therapeutics in a note issued to investors on Thursday, March 27th. Wedbush analyst D. Nierengarten now expects that the company will post earnings of ($0.40) per share for the quarter, down from their prior […]
Bicara Therapeutics Inc. (NASDAQ:BCAX – Free Report) – Equities research analysts at Wedbush cut their Q1 2025 EPS estimates for Bicara Therapeutics in a note issued to investors on Thursday, March 27th. Wedbush analyst D. Nierengarten now expects that the company will post earnings of ($0.40) per share for the quarter, down from their prior […]
